X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Procter & Gamble Health with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs DR. REDDYS LAB - Comparison Results

PROCTER & GAMBLE HEALTH     Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH DR. REDDYS LAB PROCTER & GAMBLE HEALTH/
DR. REDDYS LAB
 
P/E (TTM) x 58.1 22.8 255.0% View Chart
P/BV x 10.1 3.1 326.4% View Chart
Dividend Yield % 0.3 0.8 44.0%  

Financials

 PROCTER & GAMBLE HEALTH   DR. REDDYS LAB
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-17
DR. REDDYS LAB
Mar-19
PROCTER & GAMBLE HEALTH/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs1,3582,875 47.2%   
Low Rs9331,888 49.4%   
Sales per share (Unadj.) Rs665.0930.2 71.5%  
Earnings per share (Unadj.) Rs56.6117.4 48.2%  
Cash flow per share (Unadj.) Rs72.5185.8 39.0%  
Dividends per share (Unadj.) Rs15.0020.00 75.0%  
Dividend yield (eoy) %1.30.8 156.0%  
Book value per share (Unadj.) Rs441.7844.4 52.3%  
Shares outstanding (eoy) m16.60166.07 10.0%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.72.6 67.3%   
Avg P/E ratio x20.220.3 99.8%  
P/CF ratio (eoy) x15.812.8 123.3%  
Price / Book Value ratio x2.62.8 91.9%  
Dividend payout %26.517.0 155.7%   
Avg Mkt Cap Rs m19,011395,496 4.8%   
No. of employees `0001.522.0 7.0%   
Total wages/salary Rs m1,69633,562 5.1%   
Avg. sales/employee Rs Th7,150.07,032.8 101.7%   
Avg. wages/employee Rs Th1,098.71,527.9 71.9%   
Avg. net profit/employee Rs Th608.2887.7 68.5%   
INCOME DATA
Net Sales Rs m11,040154,482 7.1%  
Other income Rs m2403,375 7.1%   
Total revenues Rs m11,279157,857 7.1%   
Gross profit Rs m1,37631,782 4.3%  
Depreciation Rs m26411,348 2.3%   
Interest Rs m0889 0.0%   
Profit before tax Rs m1,35222,920 5.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m0438 0.0%   
Extraordinary Inc (Exp) Rs m1700-   
Tax Rs m5833,858 15.1%   
Profit after tax Rs m93919,500 4.8%  
Gross profit margin %12.520.6 60.6%  
Effective tax rate %43.116.8 256.1%   
Net profit margin %8.512.6 67.4%  
BALANCE SHEET DATA
Current assets Rs m7,523111,101 6.8%   
Current liabilities Rs m2,25358,973 3.8%   
Net working cap to sales %47.733.7 141.5%  
Current ratio x3.31.9 177.3%  
Inventory Days Days5279 65.7%  
Debtors Days Days4194 43.1%  
Net fixed assets Rs m1,240101,245 1.2%   
Share capital Rs m166830 20.0%   
"Free" reserves Rs m7,167139,406 5.1%   
Net worth Rs m7,333140,236 5.2%   
Long term debt Rs m022,000 0.0%   
Total assets Rs m9,912224,656 4.4%  
Interest coverage xNM26.8-  
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x1.10.7 162.0%   
Return on assets %9.59.1 104.4%  
Return on equity %12.813.9 92.1%  
Return on capital %20.814.9 138.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,01588,673 1.1%   
Fx outflow Rs m3,04319,104 15.9%   
Net fx Rs m-2,02869,569 -2.9%   
CASH FLOW
From Operations Rs m53728,704 1.9%  
From Investments Rs m-476-7,727 6.2%  
From Financial Activity Rs m-220-21,326 1.0%  
Net Cashflow Rs m-160-314 50.8%  

Share Holding

Indian Promoters % 0.0 25.5 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 5.4 337.0%  
FIIs % 1.0 35.3 2.8%  
ADR/GDR % 0.0 18.5 -  
Free float % 29.1 15.3 190.2%  
Shareholders   28,591 75,885 37.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   SUVEN LIFESCIENCES  SUN PHARMA  SANOFI INDIA  FDC LTD.  SHASUN PHARMA  

Compare PROCTER & GAMBLE HEALTH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slips below 38,000-Mark; Yes Bank Jumps 9%(12:30 pm)

Share markets in India are presently trading deep in the red as investors were disappointed after the government refused any respite to foreign investors.

Related Views on News

BAJAJ FINSERV Plunges by 5%; BSE 500 Index Down 0.7% (Market Updates)

Jul 22, 2019 | Updated on Jul 22, 2019

BAJAJ FINSERV share price has plunged by 5% and its current market price is Rs 7,556. The BSE 500 is down by 0.7%. The top gainers in the BSE 500 Index are YES BANK (up 7.7%) and SUN PHARMA ADV. RES. (up 4.8%). The top losers are BAJAJ FINSERV (down 5.3%) and PROCTER & GAMBLE HEALTH (down 5.2%).

PROCTER & GAMBLE HEALTH Plunges by 5%; BSE HEALTHCARE Index Up 0.6% (Market Updates)

Jul 22, 2019 | Updated on Jul 22, 2019

PROCTER & GAMBLE HEALTH share price has plunged by 5% and its current market price is Rs 4,618. The BSE HEALTHCARE is up by 0.6%. The top gainers in the BSE HEALTHCARE Index are SUN PHARMA ADV. RES. (up 5.1%) and SUN PHARMA (up 4.1%). The top losers is PROCTER & GAMBLE HEALTH (down 5.4%)..

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

The Electric Vehicle Disruption is Great News for this Smallcap Stock(Profit Hunter)

Jul 15, 2019

While big auto makers are finding the transition difficult and crying foul, this small cap company is already leading and benefitting from the electric vehicle disruption in the auto sector.

7 Stocks to Profit From an Irreversible Trend(The 5 Minute Wrapup)

Jul 18, 2019

Credit growth is likely to accelerate in India in the next decade. Here's how you can benefit from this megatrend.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock(The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Jul 22, 2019 02:59 PM

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH - DR. REDDYS LAB COMPARISON

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS